Alpha Tau Medical Reports Q1 2025 Financials, Focuses on Future Growth in Cancer Treatment Innovations
Alpha Tau Medical Ltd. reported a GAAP EPS of -$0.11 for Q1 2025, but remains focused on advancing its cancer treatment technologies and expanding its market presence.
2 minutes to read